Research News

Duke University and Penn State receive $3.2 million from NIH to bioprint a breathing lung model for flu-bacteria research and vaccine breakthroughs.

This change ensures continued access to critical services in a more sustainable, cost-effective way, plus new offerings and higher standards for clinical research.

Research from the lab of Staci Bilbo, PhD, adds to a growing body of work showing the brain doesn’t develop on its own.

When the gut, lungs, or skin encounter harmful bacteria or fungi, many different immune system cells can respond. One type, interleukin-17-producing γδ T (Tγδ17) cells, are usually helpful, but if they get out of balance, they can contribute to autoimmune diseases or even help cancer grow.

Thanks to the collaborative work of immunologist José Ramón Conejo-Garcia, MD, PhD, and cancer specialist Scott Antonia, MD, PhD, CAR-T cell therapy may soon help more patients fight cancer.

The National Institutes of Health's proposal to cap reimbursement of facilities and administrative (F&A) costs on research grants at 15% would significantly slow or cease scientific and biomedical research at Duke and other research institutions. Here is an explanation of what F&A costs are and why they are such a critical piece of the research endeavor.

Marco L. Davila, MD, PhD, of Roswell Park Comprehensive Cancer Center, will present, “Mechanisms of Toxicity and Treatment Resistance to CD19- targeted CART cells” at Duke Cancer Institutes’ Seminar Series on Wednesday, January 22, 2025, at 8AM.

Building on research that has linked immune responses with certain neurobehavioral conditions, researchers at Duke Health have identified how a key infection-fighting function is involved in triggering hyperactive behaviors in mice

Joshua Hatterschide of Carolyn Coyne's Lab was awarded a prestigious F32 grant from the National Institute of Environmental Health Sciences (NIEHS).